The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission
Abstract
BACKGROUND AND AIM: Studies have identified abnormal characteristics of the gut microbiota in patients with active IBD, but whether the changes are causal or secondary to inflammation remains uncertain. We investigated dynamics of fecal microbiota in ulcerative colitis (UC) during remission by genomic technology. PATIENTS AND METHODS: Patients in clinical remission and on stable maintenance mesalazine therapy were recruited (N = 33). Fecal samples were collected at regular intervals over a period of 1 yr. Sixteen patients who remained in remission and eight healthy controls were included in the analysis. Variable V6 to V8 regions of the 16S rRNA gene in DNA extracts from fecal samples were amplified by polymerase chain reaction. Amplicons were separated by denaturant gradient gel electrophoresis, band profiles were compared by software, and similarity indices were calculated from densitometric curves. RESULTS: Band profiles showed unique patterns with low similarity index between individuals, suggesting host specificity in the predominant microbiota. Within the same individual, profiles were stable in controls but varied notably over time in patients. In controls, the similarity index was remarkably stable (78 +/- 8% mean +/- SD) over a period of 24 months. However, patients showed a steady decline in similarity index versus the initial profile, dropping down to 42 +/- 24% at month 3 of follow-up and to 23 +/- 19% at month 12 (P < 0.001). Biodiversity of the dominant microbiota, as estimated by number of bands, was lower in patients (17 +/- 4) than controls (23 +/- 4, P < 0.01). CONCLUSION: Molecular analysis of fecal bacteria in patients with inactive UC shows low biodiversity and temporal instability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a decreased complexity in composition, with a loss of normal anaerobic bacteria [33] , a temporary composition instability during clinical remission [34] , and a dysbiosis towards selected microorganisms, with over-and under-representation of certain species [35] .”
From Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis (2014) · cites this paper as [34]
Citations
Cites
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,490
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
Self-citationLoftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,106
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Suau, A., Bonnet, R., Sutren, M., Godon, J.-J., Gibson, G. R., Collins, M. D., & Doré, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.11.4799-4807.1999 · Cited by 1,490
Zoetendal, E. G., Akkermans, A. D. L., & de Vos, W. M. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.10.3854-3859.1998 · Cited by 1,360
A simple clinical colitis activity index
Walmsley, R. S., Ayres, R., Pounder, R. E., & Allan, R. N. (1998) · Gut · doi:10.1136/gut.43.1.29 · Cited by 1,320
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311
Rapid silver staining and recovery of PCR products separated on polyacrylamide gels.
Cj, S., Neto, E. D., & Aj, S. (1994) · PubMed · Cited by 1,179
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,053
Cited by
Sorted by citations
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,595
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoüe, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2017) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,440
Dynamics of the human gut microbiome in inflammatory bowel disease
Halfvarson, J., Brislawn, C. J., Lamendella, R., Vázquez-Baeza, Y., Walters, W. A., Bramer, L. M., D'Amato, M., Bonfiglio, F., McDonald, D., Gonzalez, A., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.4 · Cited by 1,204
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160
Self-citationChronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164
Stress and stability: applying the Anna Karenina principle to animal microbiomes
Zaneveld, J. R., McMinds, R., & Vega Thurber, R. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.121 · Cited by 977
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930
Guinane, C. M., & Cotter, P. D. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13482996 · Cited by 884
The gut microbiota and inflammatory bowel disease
Matsuoka, K., & Kanai, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0454-4 · Cited by 804
Intestinal microbiota in human health and disease: the impact of probiotics
Gerritsen, J., Smidt, H., Rijkers, G. T., & de Vos, W. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0229-7 · Cited by 724
Walker, A. W., Sanderson, J. D., Churcher, C. M., Parkes, G. C., Hudspith, B. N., Rayment, N. B., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 727
Lepage, P., Häsler, R., Spehlmann, M. E., Rehman, A., Žvirblienė, A., Begun, A., Ott, S. J., Kupčinskas, L., Dore, J. M., Raedler, A., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.011 · Cited by 592
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Zuo, T., & Ng, S. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02247 · Cited by 605
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
Geirnaert, A., Calatayud, M., Grootaert, C., Laukens, D., Devriese, S., Smagghe, G. J., Vos, M. D., Boon, N., & de Wiele, T. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-11734-8 · Cited by 452
The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
Chassaing, B., & Darfeuille–Michaud, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.054 · Cited by 443
Role of priority effects in the early-life assembly of the gut microbiota
Sprockett, D., Fukami, T., & Relman, D. A. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.173 · Cited by 419
Microbes and the gut‐brain axis
Bercik, P., Collins, S. M., & Verdu, E. F. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01906.x · Cited by 417
RETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedImplication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
Stolfi, C., Maresca, C., Monteleone, G., & Laudisi, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020289 · Cited by 370
Toll-like receptors in inflammatory bowel diseases: A decade later
Cario, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21282 · Cited by 357
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
Guo, X. Y., Liu, X. J., & Hao, J. Y. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12849 · Cited by 346
Packey, C. D., & Sartor, R. B. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832a8a5d · Cited by 319
Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent
Crost, E. H., Tailford, L. E., Gall, G. L., Fons, M., Henrissat, B., & Juge, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076341 · Cited by 325
Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing
Loesche, M. A., Gardner, S. E., Kalan, L., Horwinski, J., Zheng, Q., Hodkinson, B. P., Tyldsley, A. S., Franciscus, C. L., Hillis, S. L., Mehta, S. D., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.009 · Cited by 313
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
Yao, D., Dai, W., Dong, M., Dai, C., & Wu, S. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103751 · Cited by 318
Alterations in the gut microbiome of children with severe ulcerative colitis
Michail, S. K., Durbin, M. D., Turner, D., Griffiths, A. M., Mack, D. R., Hyams, J., LeLeiko, N. S., Kenche, H., Stolfi, A., & Wine, E. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22860 · Cited by 281
Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity
Yamamoto, E. A., & Jørgensen, T. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03141 · Cited by 271
Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., Guarner, F., & Antolı́n, M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12365 · Cited by 249
Self-citationJonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H. J., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 233
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Noor, S. O., Ridgway, K., Scovell, L., Kemsley, E. K., Lund, E. K., Jamieson, C., Johnson, I. T., & Narbad, A. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-134 · Cited by 227
The Cutaneous Microbiome and Wounds: New Molecular Targets to Promote Wound Healing
Johnson, T. R., Gómez, B. I., McIntyre, M. K., Dubick, M. A., Christy, R. J., Nicholson, S. E., & Burmeister, D. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092699 · Cited by 219
The intestinal microbiota and its role in human health and disease
Kataoka, K. (2016) · The Journal of Medical Investigation · doi:10.2152/jmi.63.27 · Cited by 223
Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review
Prideaux, L., Cruz, P. P. D., Ng, S. C., & Kamm, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21903 · Cited by 209
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 184
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease
Orel, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11505 · Cited by 177
Aldars‐García, L., Chaparro, M., & Gisbert, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050977 · Cited by 181
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 174
Intestinal microbiota: A source of novel biomarkers in inflammatory bowel diseases?
Berry, D., & Reinisch, W. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.005 · Cited by 154
Reduced Diversity and Imbalance of Fecal Microbiota in Patients with Ulcerative Colitis
Nemoto, H., Kataoka, K., Ishikawa, H., Ikata, K., Arimochi, H., Iwasaki, T., Ohnishi, Y., Kuwahara, T., & Yasutomo, K. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2236-y · Cited by 152
Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., Tameda, M., Shiraki, K., Ito, M., Takei, Y., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4398 · Cited by 130
Garg, M., Hendy, P., Ding, N. S., Shaw, S., Hold, G. L., & Hart, A. L. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy052 · Cited by 131
Liu, Z., Liu, F., Wang, W., Sun, C., Gao, D. M., Ma, J., Hussain, M. A., Xu, C., Jiang, Z., & Hou, J. (2020) · Food & Function · doi:10.1039/c9fo02992c · Cited by 125
Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
Pisani, A., Rausch, P., Bang, C., Ellul, S., Tabone, T., Cordina, C. M., Zahra, G., Franke, A., & Ellul, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00616-22 · Cited by 137
Duytschaever, G., Huys, G., Bekaert, M., Boulanger, L., De Boeck, K., & Vandamme, P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05933-11 · Cited by 114
Immune aspects of the pathogenesis of inflammatory bowel disease
Hisamatsu, T., Kanai∥, T., Mikami, Y., Yoneno∥, K., Matsuoka, K., & Hibi∥, T. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.10.008 · Cited by 117
Gulamhusein, A. F., Eaton, J. E., Tabibian, J. H., Atkinson, E. J., Juran, B. D., & Lazaridis, K. N. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.55 · Cited by 115
Intestinal microbiota and ulcerative colitis
Ohkusa, T., & Koido, S. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.07.010 · Cited by 113
Rethinking Diet to Aid Human–Microbe Symbiosis
Derrien, M., & Veiga, P. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.011 · Cited by 118
Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients
Galloway-Peña, J., Smith, D. P., Sahasrabhojane, P. V., Wadsworth, W. D., Fellman, B. M., Ajami, N. J., Shpall, E. J., Daver, N. G., Guindani, M., Petrosino, J. F., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0409-1 · Cited by 118
Kong, G., Ellul, S., Narayana, V. K., Kanojia, K., Tran, H., Li, S., Renoir, T., Cao, K. L., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105199 · Cited by 111
Shobar, R., Velineni, S., Keshavarzian, A., Swanson, G. R., DeMeo, M. T., Melson, J. E., Losurdo, J., Engen, P. A., Sun, Y., Koenig, L., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.54 · Cited by 110
Constante, M., Fragoso, G., Lupien‐Meilleur, J., Calvé, A., & Santos, M. M. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001089 · Cited by 110
Walujkar, S. A., Dhotre, D. P., Marathe, N. P., Lawate, P. S., Bharadwaj, R. S., & Shouche, Y. S. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-22 · Cited by 107
Zheng, H., Chen, M., Li, Y., Wang, Y., Lin, W., Liao, Z., Wang, M., Ma, F., Liao, Q., & Xie, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01703 · Cited by 106
Sivignon, A., de Vallée, A., Barnich, N., Denizot, J., Darcha, C., Pignède, G., Vandekerckove, P., & Darfeuille–Michaud, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000280 · Cited by 101
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
Cruz, P. P. D., Prideaux, L., Wagner, J., Ng, S. C., McSweeney, C. S., Kirkwood, C. D., Morrison, M., & Kamm, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21751 · Cited by 97
Mechanisms of Microbe–Host Interaction in Crohn’s Disease: Dysbiosis vs. Pathobiont Selection
Buttó, L. F., Schaubeck, M., & Haller, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00555 · Cited by 97
Prideaux, L., Kang, S., Wagner, J., Buckley, M. J., Mahar, J. E., Cruz, P. P. D., Wen, Z., Chen, L., Xia, B., van Langenberg, D. R., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435759.05577.12 · Cited by 92
Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice
Tian, Z., Liu, J., Liao, M., Li, W., Zou, J., Han, X., Kuang, M., Shen, W., & Li, H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4060-2 · Cited by 82
Probiotics in the Treatment of Inflammatory Bowel Disease
Guandalini, S., & Sansotta, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_319 · Cited by 70
Fecal microbiota in pouchitis and ulcerative colitis
Li, K., Wang, J.-L., Wei, J., Gao, S.-Y., Zhang, Y., Wang, L.-T., & Liu, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i40.8929 · Cited by 68
Dupaul-Chicoine, J., Dagenais, M., & Saleh, M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcac7 · Cited by 68
Khalil, N. A., Walton, G., Gibson, G. R., Tuohy, K. M., & Andrews, S. C. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.825700 · Cited by 66
Bugging inflammation: role of the gut microbiota
Shen, S., & Wong, C. H. Y. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.12 · Cited by 67
Cai, Y., Liu, W., Lin, Y., Zhang, S., Zou, B., Xiao, D., Lin, L., Zhong, Y., Zheng, H., Liao, Q., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14583 · Cited by 64
Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity
Esquerre, N., Basso, L., Defaye, M., Vicentini, F., Cluny, N. L., Bihan, D. G., Hirota, S. A., Schick, A., Jijon, H. B., Lewis, I. A., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.003 · Cited by 67
Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
Pavel, F. M., Vesa, C. M., Gheorghe, G., Diaconu, C. C., Stoicescu, M., Munteanu, M. A., Babeş, E. E., Ţiţ, D. M., Toma, M. M., & BUNGAU, S. G. (2021) · Diagnostics · doi:10.3390/diagnostics11061090 · Cited by 67
Bacterial Flora in Inflammatory Bowel Disease
Marteau, P. R. (2009) · Digestive Diseases · doi:10.1159/000268128 · Cited by 63
Mechanisms of Colonization Resistance Against Clostridioides difficile
Pike, C. M., & Theriot, C. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa408 · Cited by 66
Role of Microbiome and Antibiotics in Autoimmune Diseases
Vangoitsenhoven, R., & Cresci, G. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10489 · Cited by 61
The human intestinal microbiota
Dore, J. M., & Corthier, G. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70015-4 · Cited by 67
Du, Z., Hudcovic, T., Mrázek, J., Kozáková, H., Šrůtková, D., Schwarzer, M., Tlaskalová‐Hogenová, H., Kostovčík, M., & Kverka, M. (2015) · Gut Pathogens · doi:10.1186/s13099-015-0080-2 · Cited by 54
Analysis of Gut Microbiome and Diet Modification in Patients with Crohn’s Disease
Walters, S. S. (2014) · SOJ Microbiology & Infectious Diseases · doi:10.15226/sojmid/2/3/00122 · Cited by 54
Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation
Glymenaki, M., Singh, G., Brass, A., Warhurst, G., McBain, A. J., Else, K. J., & Cruickshank, S. M. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001118 · Cited by 53
Yılmaz, B., Spalinger, M. R., Biedermann, L., Franc, Y., Fournier, N., Rossel, J., Juillerat, P., Rogler, G., Macpherson, A. J., & Scharl, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199664 · Cited by 55
Ellermann, M., Gharaibeh, R. Z., Maharshak, N., Peréz-Chanona, E., Jobin, C., Carroll, I. M., Arthur, J. C., Plevy, S. E., Fodor, A. A., Brouwer, C., et al. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1599794 · Cited by 54
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis
Chen, W.-X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15657 · Cited by 52
The role of inflammation in temporal shifts in the inflammatory bowel disease mucosal microbiome
Kiely, C. J., Pavli, P., & O'Brien, C. L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1448742 · Cited by 49
Yeom, Y., Kim, B. S., Kim, S.-J., & Kim, Y. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1456-7 · Cited by 44
The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview
M’Koma, A. E. (2018) · Gastrointestinal Disorders · doi:10.3390/gidisord1010007 · Cited by 46
Thomann, A., Mak, J. W. Y., Zhang, J., Wüstenberg, T., Ebert, M. P., Sung, J. J. �., Bernstein, C. N., Reindl, W., & Ng, S. C. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15787 · Cited by 44
Al-Amrah, H., Saadah, O. I., Mosli, M. H., Annese, V., Al-Hindi, R. R., Edris, S., Alshehri, D., Alatawi, H. A., Alatawy, M., & Bahieldin, A. (2023) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_368_22 · Cited by 41
Bacteria in the pathogenesis of inflammatory bowel disease
Flanagan, P. K., Campbell, B. J., & Rhodes, J. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391067 · Cited by 41
Influences of Intestinal Bacteria in Human Inflammatory Bowel Disease
Vanderploeg, R., Panaccione, R., Ghosh, S. K., & Rioux, K. P. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.008 · Cited by 39
Jalanka, J., Cheng, J., Hiippala, K., Ritari, J., Salojärvi, J., Ruuska, T., Kalliomäki, M., & Satokari, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176044 · Cited by 37
Satokari, R. M. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.966320 · Cited by 39
Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children
Guandalini, S., Cernat, E., & Moscoso, D. I. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0067 · Cited by 38
Lacroix, V., Cassard, A., Mas, E., & Barreau, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011255 · Cited by 36
The evidence for fungus in Crohn’s disease pathogenesis
Miyoshi, J., Sofia, M., & Pierre, J. F. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-018-0886-9 · Cited by 37
Bacteria as Trigger for Chronic Gastrointestinal Disorders
Marteau, P. R., & Chaput, U. (2011) · Digestive Diseases · doi:10.1159/000323879 · Cited by 34
Assadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1426954 · Cited by 35
Reciprocal interaction of diet and microbiome in inflammatory bowel diseases
Schaubeck, M., & Haller, D. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000216 · Cited by 33
Emerging Nanotechnologies and Microbiome Engineering for the Treatment of Inflammatory Bowel Disease
Abed, O. A., Attlassy, Y., Xu, J., Han, K., & Moon, J. J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00222 · Cited by 34
van Schewick, C. M., Nöltner, C., Abel, S., Burns, S. O., Workman, S., Symes, A., Guzman, D., Proietti, M., Bulashevska, A., Moreira, F., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01654 · Cited by 32
Metadata
- Authors
- Martinez, C., Antolin, M., Santos, J., Torrejon, A., Casellas, F., Borruel, N., Guarner, F., & Malagelada, J.-R.
- Affiliations
- Vall d'Hebron Hospital Universitari (ES)
- Instituto de Salud Carlos III (ES)
- Venue
- The American Journal of Gastroenterology
- Published
- 2008-03
- Volume
- 103
- Issue
- 3
- Pages
- 643-648
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W1967499190
- Cited by
- 208
- References
- 25
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 12 · 2023: 5 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 9 · 2018: 17 · 2017: 12 · 2016: 19 · 2015: 11 · 2014: 18 · 2013: 14 · 2012: 10
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Generalitat de Catalunya
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- ulcerative colitis, fecal microbiota, clinical remission, microbial diversity, temporal stability, 16S rRNA gene, 5-aminosalicylic acid, inflammatory bowel disease, host specificity, microbiota dynamics
- MeSH terms
- Adult, Colitis, Ulcerative, DNA, Bacterial, Electrophoresis, Polyacrylamide Gel, Feces, Female, Humans, Male, Middle Aged, Remission Induction, Polymerase Chain Reaction, DNA Fingerprinting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review